Neuroscientist Faked Data

A researcher who studied neurodegenerative diseases made up results from experiments yet to take place in order to apply for more funds.

Written byDan Cossins
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, STEAKPINBALLPaul Muchowski, a neuroscientist formerly at the Gladstone Institute for Neurological Disease in San Francisco has been censured for fabricating data in three National Institutes of Health (NIH) grant applications.

In a Federal Register notice released yesterday (January 7), the Office of Research Integrity (ORI) announced that Muchowski, who studies the molecular mechanisms underlying neurodegenerative diseases caused by protein misfolding and aggregation, reported results from experiments that had not yet been carried out in one funded NIH grant and two submitted NIH grant applications.

A dozen of Muchowski’s published papers have been cited more than 100 times, according to Thomson Scientific’s Web of Knowledge. No papers were called into question by the investigation, carried out by the Gladstone Institutes and overseen by the ORI. But Muchowski has agreed to have his research supervised for 2 years and to not serve on any NIH committees for the same period.

The Gladstone Institutes told Retraction Watch that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies